JAMI CLAY: Open Payments
NPI 1326526807 · RIPLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 14 payments from 6 companies in 2025. Trend: 2023 $65 · 2024 $482 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $136 |
| Braeburn Inc. | 2 | $101 |
| ABBVIE INC. | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: SUBLOCADE, BRIXADI, VRAYLAR, FANAPT, CAPLYTA.
Industry payments across WV — which companies pay providers there.
